146 related articles for article (PubMed ID: 38698576)
21. Hypersomnolence-hyperkinetic movement disorder in a child with compound heterozygous mutation in 4-aminobutyrate aminotransferase (ABAT) gene.
Nagappa M; Bindu PS; Chiplunkar S; Govindaraj P; Narayanappa G; Krishnan A; Bharath MM; Swaminathan A; Saini J; Arvinda HR; Sinha S; Mathuranath PS; Taly AB
Brain Dev; 2017 Feb; 39(2):161-165. PubMed ID: 27596361
[TBL] [Abstract][Full Text] [Related]
22. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
[TBL] [Abstract][Full Text] [Related]
23. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
[TBL] [Abstract][Full Text] [Related]
24. A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics.
Blackburn PR; Zimmermann MT; Gass JM; Harris KG; Cousin MA; Boczek NJ; Ross OA; Klee EW; Brazis PW; Van Gerpen JA; Atwal PS
BMC Med Genet; 2016 Dec; 17(1):93. PubMed ID: 27919237
[TBL] [Abstract][Full Text] [Related]
25. lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway.
Tao HF; Shen JX; Hou ZW; Chen SY; Su YZ; Fang JL
Oncol Rep; 2021 Feb; 45(2):469-480. PubMed ID: 33416160
[TBL] [Abstract][Full Text] [Related]
26. Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis.
Yap KL; Sysa-Shah P; Bolon B; Wu RC; Gao M; Herlinger AL; Wang F; Faiola F; Huso D; Gabrielson K; Wang TL; Wang J; Shih IeM
PLoS One; 2013; 8(7):e69099. PubMed ID: 23922682
[TBL] [Abstract][Full Text] [Related]
27. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
Carecchio M; Mencacci NE; Iodice A; Pons R; Panteghini C; Zorzi G; Zibordi F; Bonakis A; Dinopoulos A; Jankovic J; Stefanis L; Bhatia KP; Monti V; R'Bibo L; Veneziano L; Garavaglia B; Fusco C; Wood N; Stamelou M; Nardocci N
Parkinsonism Relat Disord; 2017 Aug; 41():37-43. PubMed ID: 28511835
[TBL] [Abstract][Full Text] [Related]
28. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
[TBL] [Abstract][Full Text] [Related]
29. A description of novel variants and review of phenotypic spectrum in
Briere LC; Walker MA; High FA; Cooper C; Rogers CA; Callahan CJ; Ishimura R; Ichimura Y; Caruso PA; Sharma N; Brokamp E; Koziura ME; Mohammad SS; Dale RC; Riley LG; ; Phillips JA; Komatsu M; Sweetser DA
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 33811063
[TBL] [Abstract][Full Text] [Related]
30. Gain-of-function KCNJ6 Mutation in a Severe Hyperkinetic Movement Disorder Phenotype.
Horvath GA; Zhao Y; Tarailo-Graovac M; Boelman C; Gill H; Shyr C; Lee J; Blydt-Hansen I; Drögemöller BI; Moreland J; Ross CJ; Wasserman WW; Masotti A; Slesinger PA; van Karnebeek CDM
Neuroscience; 2018 Aug; 384():152-164. PubMed ID: 29852244
[TBL] [Abstract][Full Text] [Related]
31. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.
He W; Zhu X; Tang X; Xiang X; Yu J; Sun H
Anticancer Drugs; 2022 Jan; 33(1):e336-e348. PubMed ID: 34419960
[TBL] [Abstract][Full Text] [Related]
32. Clinical Phenotype in Individuals With Birk-Landau-Perez Syndrome Associated With Biallelic
Steel DBD; Danti FR; Abunada M; Kamien B; Malhotra S; Topf M; Kaliakatsos M; Valentine J; Nemeth AH; Jayawant S; Reid KM; Mankad K; Sudhakar S; Ben-Pazi H; Barwick K; Kurian MA
Neurology; 2023 May; 100(21):e2214-e2223. PubMed ID: 37041080
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.
Blok MJ; Spruijt L; de Coo IF; Schoonderwoerd K; Hendrickx A; Smeets HJ
J Med Genet; 2007 Apr; 44(4):e74. PubMed ID: 17400793
[TBL] [Abstract][Full Text] [Related]
34. Hyperkinetic stereotyped movements in a boy with biallelic CNTNAP2 variants.
Scala M; Anijs M; Battini R; Madia F; Capra V; Scudieri P; Verrotti A; Zara F; Minetti C; Vernes SC; Striano P
Ital J Pediatr; 2021 Oct; 47(1):208. PubMed ID: 34641913
[TBL] [Abstract][Full Text] [Related]
35. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
[TBL] [Abstract][Full Text] [Related]
36. A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype.
van der Weijden MCM; Rodriguez-Contreras D; Delnooz CCS; Robinson BG; Condon AF; Kielhold ML; Stormezand GN; Ma KY; Dufke C; Williams JT; Neve KA; Tijssen MAJ; Verbeek DS
Mov Disord; 2021 Mar; 36(3):729-739. PubMed ID: 33200438
[TBL] [Abstract][Full Text] [Related]
37. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Shan W; Li J; Bai Y; Lu X
Tumour Biol; 2016 Apr; 37(4):5203-11. PubMed ID: 26553360
[TBL] [Abstract][Full Text] [Related]
38. Electroclinical history of a five-year-old girl with GRIN1-related early-onset epileptic encephalopathy: a video-case study.
Pironti E; Granata F; Cucinotta F; Gagliano A; Efthymiou S; Houlden H; Salpietro V; Di Rosa G
Epileptic Disord; 2018 Oct; 20(5):423-427. PubMed ID: 30355546
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic modeling of the PNPT1:c.1453A>G variant as a cause of mitochondrial dysfunction and autosomal recessive deafness; expanding the neuroimaging and clinical features.
Hosseini Bereshneh A; Rezaei Z; Jafarinia E; Rajabi F; Ashrafi MR; Tavasoli AR; Garshasbi M
Mitochondrion; 2021 Jul; 59():1-7. PubMed ID: 33812062
[TBL] [Abstract][Full Text] [Related]
40. Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Zhang W; Mao W; Xu E; Chhetri JK; Chan P
Int J Neurosci; 2020 Dec; 130(12):1278-1281. PubMed ID: 32075473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
